Interview with Richard Hayes by Casey Walker
By Casey Walker,
Wild Duck Review
| 05. 31. 1999
Human Genetic Engineering
Richard Hayes Biography: is a doctoral candidate in Energy and Resources at U.C. Berkeley. His work focuses on long-term scenarios of economic well-being, ecological integrity, social equity and technological change. Rich is director of Genetic Crossroads, an activist organization primarily critiquing human germline engineering and cloning technologies; and is a member of the human genetics committee of the Council for Responsible Genetics. Rich has long been active as an organizer in progressive social and political movements. He served most recently as chair of the Sierra Club's global warming campaign committee, and before that as assistant political director and director of volunteer development on the national Sierra Club staff. Contact information:
rhayes@socrates.berkeley.edu
Casey Walker: Will you describe how you came to realize the significance of developments in human genetic manipulation and why you consider public involvement a matter of urgency?
Rich Hayes: As part of my dissertation studies at Berkeley I wanted to learn about the new human genetic technologies and their social implications. I did course work in genetics and began attending conferences. I was stunned by what I...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...